Navigation Links
Varian Medical Systems Announces New Management Positions
Date:10/3/2011

o Mr. Wilson.  Ms. Kennedy has been serving as Vice President and General Manager of Customer Support Services for Varian Oncology Systems where she has helped to build annual sales from under $300 million to greater than $600 million since assuming this responsibility in 2006.  Ms. Kennedy joined Varian in 1997 beginning as a product marketing manager before being appointed to manage Oncology Systems marketing in 2001.  She took on the additional responsibility of managing Oncology's engineering function in 2002.  Prior to joining Varian, Ms. Kennedy worked with Siemens Medical and Radiation Oncology Computer Systems in product sales and marketing roles.  She holds a BS in Radiation Oncology and a BS in Psychology from Wayne State University and an MS in medical physics from the University of Colorado Health Sciences Center.

Patrick Joda, 53, Vice President of Oncology Worldwide Engineering, will step into the role of Vice President and General Manager of Oncology Customer Support Services replacing and reporting to Ms. Kennedy.  He has made significant contributions to improved manufacturing efficiency and he played a key management role in the launch of the company's successful TrueBeam platform for radiotherapy and radiosurgery.  Mr. Joda joined Varian in 2005 as Senior Director of Manufacturing for Oncology Systems and was quickly promoted to Vice President of Worldwide Operations in 2006.  He was named Oncology Systems Vice President of Worldwide Engineering in 2009.  Prior to joining Varian, Mr. Joda had a 22-year career with GE.  He holds BS and MS degrees from the University of Wisconsin, Stout.  

Martin Amstutz, 47, has been appointed Vice President of Worldwide Engineering for Oncology Systems, replacing Mr. Joda in that role.  Mr. Amstutz has been with Varian since 1990 and has been managing the company's research and development facility in Baden, Switzerland where the company dev
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014  For many ... surgery often means facing the prospect of large, ... be imagined, regular activities are also impacted, such ... the severity of the problem, some patients even ... which can even lead to permanent damage for ...
(Date:9/22/2014)... SAN FRANCISCO , Sept. 22, 2014  Sutro ... FierceBiotech as one of 2014,s Fierce 15 ... promising private biotechnology companies in the industry.  ... A-list group of backers as well as industry partners ... developing antibody-drug conjugates and bispecifics," says John Carroll ...
(Date:9/22/2014)... Sept. 22, 2014  Seres Health, a clinical-stage therapeutics ... human microbiome, today announced that it has been named ... 15 biotechnology companies, designating it as one of the ... "Amid a great deal of ain,t-it-cool science ... and commitment to practical therapeutic development," says Damian ...
Breaking Medicine Technology:Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Six-Month Data Show Bifeprunox Maintained Stability,Significantly Longer ... and,Lipid Profile Comparable with Placebo , MARIETTA, ... - Solvay,Pharmaceuticals, Inc., Wyeth Pharmaceuticals, a division ... study results on,bifeprunox, an investigational treatment for ...
... Support FDA Approval of SEROQUEL XR--, WILMINGTON, ... announced that two analyses from a large-scale,study ... (quetiapine,fumarate) Extended-Release Tablets, a once-daily medicine for ... presented today,at the annual meeting of the ...
Cached Medicine Technology:New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
(Date:9/22/2014)... Asians living in Canada have a higher rate of ... with while people, McMaster researchers have found. , ... Medical Association Journal (CMAJ Open) and may be ... fastest-growing ethnic groups in the country is the more ... comprising about three percent of the population. They include ...
(Date:9/22/2014)... researchers have published a pilot study showing the ... people with multiple sclerosis (MS). Improvements were ... and pain. "Development and effectiveness of a ... Description and outcomes" was epublished ahead of print ... of MS Care (doi: 10.7224/1537-2073.2013-045). The authors ...
(Date:9/22/2014)... -- Two new prescription devices approved by the U.S. ... for people with migraine headaches who don,t tolerate migraine ... device -- the Cefaly -- is designed to prevent ... is meant to be used when migraines first start, ... been looking for alternative migraine treatments. Because these devices ...
(Date:9/22/2014)... Severe weather can occur with little warning, so it’s ... of National Preparedness Month, Amica Insurance is offering the ... unexpected:, , Build an emergency supply kit. It ... gallon of water per person per day for at least 72 ... includes pets so your family knows what to do and where ...
(Date:9/22/2014)... September 22, 2014 The New York ... of Surgery at the Icahn School of Medicine at ... York Group for Plastic Surgery gives residents of New ... a team of world-renowned plastic surgeons performing innovative reconstructive ... Salzberg, MD, who led NYGPS, was named the Director ...
Breaking Medicine News(10 mins):Health News:Higher risk of heart disease for South Asians in Canada 2Health News:Noninvasive Devices May Help Migraines, FDA Says 2Health News:Amica Shares Tips for National Preparedness Month 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3
... San Diego, CA, August 18, 2009 While video gaming ... adults, research shows that the average age of players in ... Disease Control and Prevention (CDC), Emory University and Andrews University ... from 19 to 90 in the Seattle-Tacoma area on health ...
... INDIANAPOLIS, Aug. 17 Eli Lilly and Company (NYSE: ... for the Eastern District of Michigan has granted a motion by ... ,826 patent, or method-of-use patent, for Gemzar((R)) (gemcitabine HCl for injection) ... no bearing on Gemzar,s compound patent, which remains valid until November ...
... , , MIAMI, Aug. 17 In the ... Make You Thin , writer John Cloud tells us that these days, the ... wasting their time. He says that "exercise, in other words, isn,t necessarily helping ... After reading this article, Marta Montenegro is on a ...
... , WASHINGTON, Aug. 17 Earlier this ... Abbey College, a Roman-Catholic institution, must provide insurance coverage for ... http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO ) , , The ruling goes ... state law which provides for exemption to for religious entities. ...
... A new study shows that elderly patients who ... ulcer bleeding had a two-day shorter hospital stay and ... patients who did not receive endoscopy within the first ... Center in Cleveland, Ohio, note that unless specific contraindications ...
... benign, others might pose dangers, experts say , MONDAY, ... skin can "trap" large amounts of indoor ozone, then "spit" ... the skin and the lungs, new research suggests. , "They ... ozone and cause more irritation to the skin," explained one ...
Cached Medicine News:Health News:New study finds links between video-game playing and health risks in adults 2Health News:New study finds links between video-game playing and health risks in adults 3Health News:U.S. District Court Rules Against Lilly Regarding Gemzar Patent 2Health News:U.S. District Court Rules Against Lilly Regarding Gemzar Patent 3Health News:U.S. District Court Rules Against Lilly Regarding Gemzar Patent 4Health News:Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazine's Article 'Why Exercise Won't Make You Thin' Sends the Wrong Message 2Health News:Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazine's Article 'Why Exercise Won't Make You Thin' Sends the Wrong Message 3Health News:Editor-In-Chief of SOBeFiT Magazine, Marta Montenegro, Says Time Magazine's Article 'Why Exercise Won't Make You Thin' Sends the Wrong Message 4Health News:Family Research Council President Tony Perkins Asks: Is This What President Obama Means by 'Robust' Conscience Protections? 2Health News:Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 2Health News:Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 3Health News:Endoscopy within 24 hours shows better outcomes in elderly with peptic ulcer bleeding 4Health News:Toxins May Form When Skin, Indoor Ozone Meet 2Health News:Toxins May Form When Skin, Indoor Ozone Meet 3
Mounted on an extremely lightweight,and flexible cotton headband, the,Trueview Sport adjusts around the head,and the crown strap for a comfortable,and secure fit,...
The Convertible lets you attach the,High Lite optic directly to your loupes....
Mounted on a remarkably lightweight and,flexible cotton headband with crown strap,the Sport is fully adjustable....
... content (93% by volume) of any DBM ... handling characteristics, which will enhance any graft ... or as a graft extender for larger ... high molecular weight biocompatible carrier allows DBX ...
Medicine Products: